×
QQQ   288.80 (+0.64%)
AAPL   142.92 (+0.96%)
MSFT   266.21 (+1.28%)
META   169.77 (+0.94%)
GOOGL   2,291.44 (+1.16%)
AMZN   114.33 (+0.73%)
TSLA   695.20 (-0.57%)
NVDA   151.30 (+1.11%)
NIO   20.83 (-6.09%)
BABA   119.12 (-0.84%)
AMD   75.35 (+0.20%)
MU   57.37 (+1.13%)
CGC   2.65 (-2.21%)
T   21.09 (-0.38%)
GE   61.57 (-0.74%)
F   11.06 (-1.25%)
DIS   96.08 (-1.13%)
AMC   12.57 (-1.64%)
PFE   52.75 (+2.15%)
PYPL   73.24 (-1.56%)
NFLX   184.06 (-0.98%)
QQQ   288.80 (+0.64%)
AAPL   142.92 (+0.96%)
MSFT   266.21 (+1.28%)
META   169.77 (+0.94%)
GOOGL   2,291.44 (+1.16%)
AMZN   114.33 (+0.73%)
TSLA   695.20 (-0.57%)
NVDA   151.30 (+1.11%)
NIO   20.83 (-6.09%)
BABA   119.12 (-0.84%)
AMD   75.35 (+0.20%)
MU   57.37 (+1.13%)
CGC   2.65 (-2.21%)
T   21.09 (-0.38%)
GE   61.57 (-0.74%)
F   11.06 (-1.25%)
DIS   96.08 (-1.13%)
AMC   12.57 (-1.64%)
PFE   52.75 (+2.15%)
PYPL   73.24 (-1.56%)
NFLX   184.06 (-0.98%)
QQQ   288.80 (+0.64%)
AAPL   142.92 (+0.96%)
MSFT   266.21 (+1.28%)
META   169.77 (+0.94%)
GOOGL   2,291.44 (+1.16%)
AMZN   114.33 (+0.73%)
TSLA   695.20 (-0.57%)
NVDA   151.30 (+1.11%)
NIO   20.83 (-6.09%)
BABA   119.12 (-0.84%)
AMD   75.35 (+0.20%)
MU   57.37 (+1.13%)
CGC   2.65 (-2.21%)
T   21.09 (-0.38%)
GE   61.57 (-0.74%)
F   11.06 (-1.25%)
DIS   96.08 (-1.13%)
AMC   12.57 (-1.64%)
PFE   52.75 (+2.15%)
PYPL   73.24 (-1.56%)
NFLX   184.06 (-0.98%)
QQQ   288.80 (+0.64%)
AAPL   142.92 (+0.96%)
MSFT   266.21 (+1.28%)
META   169.77 (+0.94%)
GOOGL   2,291.44 (+1.16%)
AMZN   114.33 (+0.73%)
TSLA   695.20 (-0.57%)
NVDA   151.30 (+1.11%)
NIO   20.83 (-6.09%)
BABA   119.12 (-0.84%)
AMD   75.35 (+0.20%)
MU   57.37 (+1.13%)
CGC   2.65 (-2.21%)
T   21.09 (-0.38%)
GE   61.57 (-0.74%)
F   11.06 (-1.25%)
DIS   96.08 (-1.13%)
AMC   12.57 (-1.64%)
PFE   52.75 (+2.15%)
PYPL   73.24 (-1.56%)
NFLX   184.06 (-0.98%)
NASDAQ:AEMD

Aethlon Medical Stock Forecast, Price & News

$0.99
-0.02 (-1.98%)
(As of 07/6/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.99
$1.08
50-Day Range
$0.89
$1.61
52-Week Range
$0.88
$6.22
Volume
518,680 shs
Average Volume
304,621 shs
Market Capitalization
$15.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.50

Aethlon Medical MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
556.6% Upside
$6.50 Price Target
Short Interest
Healthy
1.41% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.58mentions of Aethlon Medical in the last 14 days
Based on 11 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

1.57 out of 5 stars

Medical Sector

949th out of 1,426 stocks

Surgical & Medical Instruments Industry

97th out of 136 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive AEMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aethlon Medical and its competitors with MarketBeat's FREE daily newsletter.

Aethlon Medical logo

About Aethlon Medical (NASDAQ:AEMD) Stock

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.

AEMD Stock News Headlines

Aethlon Medical Q4 2022 Earnings Preview
Earnings Outlook For Aethlon Medical
Aethlon Medical (AEMD) to Release Earnings on Tuesday
/C O R R E C T I O N -- Aethlon Medical, Inc./
Aethlon Medical's Earnings Outlook
Aethlon Medical Q3 2022 Earnings Preview
See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AEMD
Fax
N/A
Employees
10
Year Founded
N/A

Company Calendar

Last Earnings
11/09/2021
Today
7/06/2022
Next Earnings (Estimated)
8/08/2022
Fiscal Year End
3/31/2023

Price Target and Rating

Average Stock Price Forecast
$6.50
High Stock Price Forecast
$9.00
Low Stock Price Forecast
$4.00
Forecasted Upside/Downside
+556.6%
Consensus Rating
Buy
Rating Score (0-4)
3
Research Coverage
1 Analysts

Profitability

Net Income
$-10,420,000.00
Net Margins
-3,542.86%
Pretax Margin
-3,544.56%

Debt

Sales & Book Value

Annual Sales
$290,000.00
Book Value
$1.10 per share

Miscellaneous

Free Float
15,645,000
Market Cap
$15.67 million
Optionable
Not Optionable
Beta
0.87














Aethlon Medical Frequently Asked Questions

Should I buy or sell Aethlon Medical stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aethlon Medical in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Aethlon Medical stock.
View analyst ratings for Aethlon Medical
or view top-rated stocks.

What is Aethlon Medical's stock price forecast for 2022?

1 brokers have issued 1 year target prices for Aethlon Medical's shares. Their AEMD stock forecasts range from $4.00 to $9.00. On average, they predict Aethlon Medical's stock price to reach $6.50 in the next year. This suggests a possible upside of 556.6% from the stock's current price.
View analysts' price targets for Aethlon Medical
or view top-rated stocks among Wall Street analysts.

How has Aethlon Medical's stock price performed in 2022?

Aethlon Medical's stock was trading at $1.86 at the start of the year. Since then, AEMD stock has decreased by 46.8% and is now trading at $0.99.
View the best growth stocks for 2022 here
.

When is Aethlon Medical's next earnings date?

Aethlon Medical is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022.
View our earnings forecast for Aethlon Medical
.

How were Aethlon Medical's earnings last quarter?

Aethlon Medical, Inc. (NASDAQ:AEMD) posted its quarterly earnings results on Tuesday, November, 9th. The medical equipment provider reported ($0.13) earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.02. The medical equipment provider had revenue of $0.13 million for the quarter, compared to analysts' expectations of $0.21 million. Aethlon Medical had a negative net margin of 3,542.86% and a negative trailing twelve-month return on equity of 48.91%. During the same period last year, the firm posted ($0.15) earnings per share.
View Aethlon Medical's earnings history
.

Who are Aethlon Medical's key executives?

Aethlon Medical's management team includes the following people:
  • Dr. Charles J. Fisher Jr., M.D., CEO, Director & Member of Extracorporeal Therapy Advisory Board (Age 75, Pay $509.14k)
  • Mr. James B. Frakes M.B.A., CFO, Sr. VP of Fin. & Sec. (Age 65, Pay $385k)
  • Mr. Steven P. Larosa M.D., Chief Medical Officer & Acting Chief Scientific Officer
  • Mr. Guy F. Cipriani BS (Eng.), MBA, Sr. VP, Chief Bus. Officer & Director (Age 52, Pay $29.75k)
  • Mr. Sunil Sawhney, Head of Clinical Studies
  • Dr. Richard H. Tullis Ph.D., Consultant (Age 77)

What other stocks do shareholders of Aethlon Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aethlon Medical investors own include Amarin (AMRN), Nokia Oyj (NOK), Vaxart (VXRT), VBI Vaccines (VBIV), Nabriva Therapeutics (NBRV), CRISPR Therapeutics (CRSP), Novavax (NVAX), OrganiGram (OGI), AT&T (T) and Aurora Cannabis (ACB).

What is Aethlon Medical's stock symbol?

Aethlon Medical trades on the NASDAQ under the ticker symbol "AEMD."

How do I buy shares of Aethlon Medical?

Shares of AEMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aethlon Medical's stock price today?

One share of AEMD stock can currently be purchased for approximately $0.99.

How much money does Aethlon Medical make?

Aethlon Medical (NASDAQ:AEMD) has a market capitalization of $15.67 million and generates $290,000.00 in revenue each year. The medical equipment provider earns $-10,420,000.00 in net income (profit) each year or ($0.70) on an earnings per share basis.

How many employees does Aethlon Medical have?

Aethlon Medical employs 10 workers across the globe.

How can I contact Aethlon Medical?

Aethlon Medical's mailing address is 9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA, 92123. The official website for Aethlon Medical is www.aethlonmedical.com. The medical equipment provider can be reached via phone at (858) 459-7800 or via email at susan@sanoonan.com.

This page (NASDAQ:AEMD) was last updated on 7/6/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.